![Henry P. Nowak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henry P. Nowak
Corporate Officer/Principal presso Cogenics Icoria, Inc.
Provenienza dei contatti di primo grado di Henry P. Nowak
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Cogenics Icoria, Inc.
![]() Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Henry P. Nowak tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Serenex, Inc.
![]() Serenex, Inc. Pharmaceuticals: MajorHealth Technology Serenex, Inc. operates as a biotechnology company that develops drugs for tumors and cancers of the blood and bone marrow. Its products include drugs for chemotherapy treatments as well as inhibitor compounds. Serenex was founded by George Young and Timothy Haystead in 2000 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Aerpio Therapeutics, Inc.
![]() Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director of Finance/CFO | |
Scioderm, Inc.
![]() Scioderm, Inc. BiotechnologyHealth Technology Scioderm, Inc. engages in the development of innovative therapies for areas of high unmet need, including orphan products. The company was founded by Robert Ryan and Robert John Coull in 2012 and is headquartered in Durham, NC. | Biotechnology | Director of Finance/CFO | |
Jibu L3C
![]() Jibu L3C Water UtilitiesUtilities Jibu L3C provides packaged drinking water services. The company is headquartered in Colorado Springs, CO. | Water Utilities | Corporate Officer/Principal | |
The State University of New York | College/University | Doctorate Degree | |
University of Warwick | College/University | Undergraduate Degree | |
Coopers & Lybrand (London)
![]() Coopers & Lybrand (London) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., Coopers & Lybrand (London) is a British company that provides accounting services. The company is based in Edinburgh, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Accelerator Services Corp
![]() Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Director of Finance/CFO | |
AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Kenan-Flagler Business School | College/University | Masters Business Admin | |
Ensys, Inc. | Corporate Officer/Principal | ||
Alexandria Agtech/Climate Innovation Acquisition Corp.
![]() Alexandria Agtech/Climate Innovation Acquisition Corp. Financial ConglomeratesFinance Alexandria Agtech/Climate Innovation Acquisition Corp. operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 18, 2021 and is headquartered in Pasadena, CA. | Financial Conglomerates | Director/Board Member | |
ALSP ORCHID ACQUISITION CORPORATION I | Financial Conglomerates | Director of Finance/CFO |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Regno Unito | 3 |
Irlanda | 2 |
Isole Cayman | 2 |
Settori
Health Technology | 6 |
Consumer Services | 4 |
Finance | 4 |
Utilities | 2 |
Commercial Services | 2 |
Posizioni
Director of Finance/CFO | 8 |
Corporate Officer/Principal | 5 |
Director/Board Member | 2 |
Private Equity Investor | 2 |
Chief Operating Officer | 1 |
Contatti più connessi
Insiders | |
---|---|
Ian Howes | 14 |
Thomas J. Colatsky | 2 |
- Borsa valori
- Insiders
- Henry P. Nowak
- Connessioni Società